Allianz Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-24,918	Closed	-$617K	–	1969
2022 Q2	$617K	Sell	24,918 -30,806	-55%	-$850K	﹤0.01%	1840
2022 Q1	$2.16M	Buy	55,724 +1,255	+2%	+$48.6K	﹤0.01%	1566
2021 Q4	$3.2M	Buy	54,469 +22,945	+73%	+$1.3M	﹤0.01%	1418
2021 Q3	$1.87M	Buy	31,524 +1,111	+4%	+$87.1K	﹤0.01%	1676
2021 Q2	$2.64M	Sell	30,413 -14,231	-32%	-$1.15M	﹤0.01%	1377
2021 Q1	$3.68M	Sell	44,644 -964	-2%	-$92.4K	﹤0.01%	1181
2020 Q4	$4.15M	Buy	+45,608	New	+$2.83M	﹤0.01%	1105
2020 Q2	–	Sell	-31,670	Closed	-$703K	–	2434
2020 Q1	$703K	Sell	31,670 -12,931	-29%	-$327K	﹤0.01%	1928
2019 Q4	$873K	Buy	44,601 +654	+1%	+$10.4K	﹤0.01%	2253
2019 Q3	$682K	Sell	43,947 -64,619	-60%	-$1.24M	﹤0.01%	2267
2019 Q2	$2.2M	Sell	108,566 -983	-0.9%	-$17.7K	﹤0.01%	1847
2019 Q1	$1.93M	Buy	109,549 +1,188	+1%	+$18.8K	﹤0.01%	1847
2018 Q4	$1.39M	Buy	108,361 +229	+0.2%	+$3.19K	﹤0.01%	1897
2018 Q3	$1.76M	Buy	+108,132	New	+$1.28M	﹤0.01%	1991
2016 Q3	–	Sell	-18,252	Closed	-$31K	–	2594
2016 Q2	$31K	Sell	18,252 -179,077	-91%	-$325K	﹤0.01%	2542
2016 Q1	$355K	Sell	197,329 -11,978	-6%	-$24.7K	﹤0.01%	2319
2015 Q4	$705K	Buy	209,307 +16,711	+9%	+$70.2K	﹤0.01%	2108
2015 Q3	$1.03M	Buy	+192,596	New	+$1.32M	﹤0.01%	1818

Other funds holding FATE